Elisabeth Bruder

Elisabeth Bruder

Auto-generated profile, based on publicly available information

Elisabeth Bruder

Universitätsspital Basel

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2004 in American Journal of Surgical Pathology
Verified
Journal Article
Closed access
EBElisabeth Bruder
Elisabeth Bruder
OPOliver Passera
Oliver Passera
DHDieter Harms
Dieter Harms
ILIvo Leuschner
Ivo Leuschner
MLMarc Ladanyi
Marc Ladanyi
HMHolger Moch
Holger Moch
A new WHO classification of renal cell carcinoma has been introduced in 2004. This classification includes the recently described renal cell carcinomas with the ASPL-TFE3 gene fusion and carcinomas with a PRCC-TFE3 gene fusion. Collectively, these tumors have been termed Xp11.2 or TFE3 translocation carcinomas, which primarily occur in children and young adults. To further study the characteristics of renal cell carcinoma in young patients and to determine their genetic background, 41 renal cell carcinomas of patients younger than 22 years were morphologically and genetically characterized. Loss of heterozygosity analysis of the von Hippel-Lindau gene region and screening for VHL gene mutations by direct sequencing were performed in 20 tumors. TFE3 protein overexpression, which correlates with the presence of a TFE3 gene fusion, was assessed by immunohistochemistry. Applying the new WHO classification for renal cell carcinoma, there were 6 clear cell (15%), 9 papillary (22%), 2 chromophobe, and 2 collecting duct carcinomas. Eight carcinomas showed translocation carcinoma morphology (20%). One carcinoma occurred 4 years after a neuroblastoma. Thirteen tumors could not be assigned to types specified by the new WHO classification: 10 were grouped as unclassified (24%), including a unique renal cell carcinoma with prominently vacuolated cytoplasm and WT1 expression. Three carcinomas occurred in combination with nephroblastoma. Molecular analysis revealed deletions at 3p25-26 in one translocation carcinoma, one chromophobe renal cell carcinoma, and one papillary renal cell carcinoma. There were no VHL mutations. Nuclear TFE3 overexpression was detected in 6 renal cell carcinomas, all of which showed areas with voluminous cytoplasm and foci of papillary architecture, consistent with a translocation carcinoma phenotype. The large proportion of TFE3 “translocation” carcinomas and “unclassified” carcinomas in the first two decades of life demonstrates that renal cell carcinomas in young patients contain genetically and phenotypically distinct tumors with further potential for novel renal cell carcinoma subtypes. The far lower frequency of clear cell carcinomas and VHL alterations compared with adults suggests that renal cell carcinomas in young patients have a unique genetic background.

1 December 2004 in European Journal of Pediatric Surgery
Verified
Journal Article
Closed access
PDF file
WMW. A. Meier-Ruge
W. A. Meier-Ruge
KAK. Ammann
K. Ammann
EBE. Bruder
E. Bruder
AHA. M. Holschneider
A. M. Holschneider
ASA. F. Schärli
A. F. Schärli
FSF. Stoss
F. Stoss
Background: Intestinal neuronal dysplasia (IND B) is still a subject of controversy. The aim of this paper is to review the present state of knowledge on IND B. A summary is given of the technical and diagnostic criteria which have to be considered in order to arrive at a reliable diagnosis. In addition, the available therapeutic interventions are discussed. Methods: Between 1992 and 2001, 3984 colonic mucosal biopsies from 1328 children were investigated. Nerve cell staining was performed on native tissue sections: 15 µm thick cryostat sections, which, after spreading and drying on a microscopic slide, have a final thickness of 4 - 5 µm, with dehydrogenase reactions (lactic dehydrogenase, nitroxide synthase, succinic dehydrogenase). The biopsies were taken 8 - 10 cm above the dentate line (proximal to the ampulla recti, because of the caudo-cranial increase of giant ganglia proximal to the 4 cm biopsy) with a sufficient amount of submucosa. The criteria for IND is 15 - 20 % submucosal giant ganglia with more than eight nerve cells in 30 sections of a single biopsy (i.e. four to seven giant ganglia). Results: The diagnosis of IND B is quantitative. A diagnosis of IND B was made over the past 10 years in 51 Hirschsprung resections (about 5 per year; 6 % of all Hirschsprung cases), and in 92 children with chronic constipation (about 9 children per year; 2.3 % incidence). Up to their fourth year of life, most children with isolated IND can be treated conservatively. This is due to the delayed maturation of the enteric nervous system which is characteristic of IND B. Only children who showed an additional hypoplastic hypoganglionosis were treated surgically. Children with Hirschsprung's disease (HD) and IND B proximal to the aganglionosis often showed, in those cases with a disseminated IND, postoperative disturbances in intestinal motility. Conclusion: The diagnosis of IND B requires that biopsies are taken proximal to the ampulla recti (about 8 - 10 cm above the dentate line) with a sufficient amount of submucosa. The biopsies must be cut rectangular to the surface of the mucosa. A diagnosis of IND B can be made only if, in the submucosa of 30 serial sections, 15 - 20 % of all ganglia are giant ganglia with more than eight nerve cells. Ganglioneuromatosis (MEN2B) must be clearly differentiated from IND. The clinical course of IND B depends on the extent of disturbed bowel innervation, the severity of motility failure, and the coexistence of MH. The conservative management of isolated IND is possible in most children. In individual cases, however, a transient enterostomy or a segmental resection is unavoidable. But: La neurodysplasie intestinale (IND B) est encore sujette à controverse. Le but de cet article est de revoir l'état actuel des connaissances sur IND B. Un résumé est donné des critères techniques et diagnostiques qui ont été considérés pour établir un diagnostic fiable. De plus, le traitement est discuté. Méthodes: Entre 1992 et 2001, 3984 biopsies coliques muqueuses de 1328 enfants ont été analysées. La préparation des cellules nerveuses était réalisée sur coupes de 15 µm d'épaisseur qui, après section au cryostat, avaient une épaisseur de 4 à 5 µm avec des réactions déhydrogénase (lactic dehydrogenase, nitroxide synthase, succinic dehydrogenase). Les biopsies étaient réalisées 8 à 10 cm au-dessus de la ligne pectinée (à proximité de l'ampoule rectale, à cause de l'augmentation caudo-craniale des cellules ganglionnaires) avec suffisamment de sous muqueuse. Le critère pour IND est 15 à 20 % de ganglions géants sous muqueux avec plus de 8 cellules nerveuses sur 30 sections d'une seule biopsie (par exemple, quatre à sept ganglions géants). Résultats: Le diagnostic de IND B est quantitatif. Un diagnostic de IND B a été fait pendant les dix dernières années sur 50 résections coliques pour maladie de Hirschsprung (approximativement 5 par an; 6 % de tous les cas de maladie de Hirschsprung) et chez 92 enfants avec une constipation chronique (environ 9 par an; 2.3 %). Jusqu'à leur quatrième année de vie, la plupart des enfants avec IND isolé ont été traités de manière conservative. Ceci est du à la maturation retardée du système nerveux entérique qui est caractéristique de IND B. Seuls les enfants qui montraient une hypoganglionose associée étaient traités chirurgicalement. Les enfants avec maladie de Hirschsprung (HD) et IND B à proximité de l'aganglionose montraient souvent des troubles de la motilité intestinale. Conclusion: Le diagnostic de IND B nécessite des biopsies, à proximité de l'ampoule rectale (environ 8 à 10 cm au-dessus de la ligne pectinée avec suffisamment de sous muqueuse. Les biopsies doivent être perpendiculaires à la surface de la muqueuse. Un diagnostic de IND B peut être fait seulement si, sur la sous muqueuse de 30 sections consécutives, 15 à 20 % de tous les ganglions sont des ganglions géants avec plus de 8 cellules nerveuses. La ganglioneuromatose (MEN2B) peut être clairement différenciée de IND. L'évolution clinique de IND B dépend de l'extension de l'intestin mal innervé, de la sévérité du désordre moteur et de l'association à MH. Le traitement conservateur de IND est possible chez la plupart des enfants. Un cas néanmoins nécessite une entérostomie transitoire ou une résection segmentaire. Antecedentes: La displasia neuronal intestinal (IND B) es todavía un tema controvertido. El objetivo de este trabajo es revisar el estado actual del conocimiento sobre IND B incluimos un resumen de los criterios técnicos y diagnósticos necesarios para un diagnóstico fiable. También mencionamos las intervenciones terapeuticas. Métodos: Entre 1992 y 2001 investigamos 3984 biopsias mucosas del colon procedentes de 1328 niños. La tinción neuronal se realizó en cortes de criostato de 15 µm tras extenderlos y secarlos en un porta con un grosor final de 4 a 5 µm mediante reacciones de deshidrogenasa (Deshidrogenasa láctica, sintasa del óxido nítrico, deshidrogenasa succínica). Se tomaron las biopsias entre 8 y 10 cm por encima de la línea pectínea (proximalmente a la ampolla rectal debido al aumento caudocraneal de ganglios gigantes por encima de la biopsia de 4 cm) con una cantidad suficiente de submucosa. Los criterios para IND fueron 15 a 20 % de ganglios gigantes submucosos con más de 8 células nerviosas en 30 cortes de una sola biopsia (4 a 7 ganglios gigantes). Resultados: El diagnóstico de IND B es cuantitativo. Un diagnóstico de IND B se hizo en los últimos 10 años en 51 resecciones por Hirschsprung (alrededor de 5 cada año, 6 % de todos los casos de Hirschsprung) y en 92 niños con constipación crónica (alrededor de 9 niños cada año, una incidencia de 2.3 %). Hasta el cuarto año de vida la mayoría de los niños con IND aislada pueden ser tratados conservadoramente. Esto de debe a la maduración retrasada del sistema nervioso entérico que es característica de IND B. Sólo fueron tratados quirúrgicamente los niños con hipoganglionismo hipoplástico suplementario. Los niños con enfermedad de Hirschsprung y con IND B proximal al aganglionismo tuvieron, en casos con IND diseminada, trastornos postoperatorios de la motilidad intestinal. Conclusión: El diagnóstico de IND B requiere que las biopsias sean tomadas proximalmente a la ampolla rectal (alrededor de 8 o 10 cm. por encima de la linea pectínea) con una cantidad suficiente de submucosa. Las biopsias deben ser cortadas perpendicularmente a la superficie de la mucosa. El diagnóstico de IND B puede ser hecho sólo si en la submucosa de 30 cortes seriados 15 a 20 % de todos los ganglios son gigantes con más de 8 neuronas. La ganglioneuromatosis (MEN2B) debe ser diferenciada claramente de la IND. El curso clínico de IND B depende de la extensión de la inervación intestinal anormal, del fallo motor y de la consistencia de aganglionismo. El tratamiento conservador de la IND aislada es posible en la mayoría de los niños. En casos individuales, sin embargo, es inevitable realizar una enterostomía o una resección segmentaria. Hintergrund-Information: Die Intestinale Neuronale Dysplasie (IND B) wird bis heute kontrovers diskutiert. Das Ziel dieser Arbeit besteht darin, einen Überblick zum gegenwärtigen Kenntnisstand der IND B zu geben. Zugleich sollen die technischen und diagnostischen Kriterien dargestellt werden, die für eine zuverlässige Diagnose der IND B notwendig sind. Außerdem werden die therapeutischen Maßnahmen erwähnt. Methodik: Zwischen 1992 und 2001 wurden 3984 Kolonschleimhaut-Biopsien von 1328 Kindern untersucht. Eine Nervenzell-Färbung wurde an nativen Gewebeschnitten (Kryostat-Schnitte von 15 µm Dicke, welche nach dem Aufziehen und Trocknen auf Objektträgern eine Enddicke von 4 - 5 µm aufweisen) mit Dehydrogenase-Reaktionen (Laktat Dehydrogenase, Nitroxid Synthase, Succinat Dehydrogenase) durchgeführt. Die Biopsien müssen 8 - 10 cm oberhalb der Linea dentata (proximal der Ampulla recti, wegen der kaudo-kranialen Zunahme der Riesenganglien oberhalb der 4-cm-Biopsie) entnommen werden und eine ausreichende Menge an Submukosa enthalten. Kriterien einer IND B sind 15 - 20 % Riesenganglien mit mehr als 8 Nervenzellen in 30 Schnitten einer Biopsie (das sind 4 - 7 Riesenganglien). Ergebnisse: Die Diagnose einer IND B muss quantitativen Kriterien gehorchen. Eine IND B wurde in den vergangenen 10 Jahren in 51 Hirschsprung Resektaten (etwa 5 Fälle pro Jahr; 6 % aller Hirschsprung Resektate) und bei 92 Kindern mit chronischer Obstipation (etwa 9 Kinder pro Jahr; eine Häufigkeit von 2,3 %) gefunden. Bis zum vierten Lebensjahr konnten die meisten Kinder mit isolierter IND B konservativ behandelt werden. Das mag zum Teil mit der für die IND B typischen verzögerten Reifung des enteralen Nervensystems zusammenhängen. Nur Kinder, welche außerdem eine hypoplastische Hypoganglionose aufwiesen, benötigten eine frühzeitige chirurgische Behandlung. Kinder mit einem Morbus Hirschsprung (MH) und einer IND B proximal der Aganglionose zeigten bei einer ausgedehnten IND B zuweilen postoperative Darmmotilitäts-Störungen. Schlussfolgerung: Die Diagnose einer IND B erfordert Biopsien, welche proximal der Ampulla recti (8 - 10 cm oberhalb der Linea dentata) mit einer ausreichenden Menge an Submukosa entnommen wurden. Die Biopsien müssen bei der histologischen Aufarbeitung exakt im rechten Winkel zur Schleimhaut-Oberfläche orientiert sein. Die Diagnose einer IND B lässt sich nur in der Submukosa von 30 Serienschnitten stellen, wenn 15 - 20 % aller Ganglien Riesenganglien mit mehr als 8 Nervenzellen sind. Eine Ganglioneuromatose (MEN2B) muss zuverlässig von einer IND B unterschieden werden. Der klinische Verlauf einer IND B ist von der Ausdehnung der gestörten Darminnervation sowie der Schwere der motorischen Störung abhängig. In diesem Zusammenhang ist natürlich auch die Koinzidenz einer IND mit einem MH zu erwähnen. In den meisten Fällen einer isolierten IND B ist eine konservative Therapie möglich. Einzelne Fälle benötigen eine temporäre Enterostomie oder vereinzelt eine segmentale Colonresektion.

10 November 2008 in BMC Developmental Biology
Verified
Journal Article
Open access
PDF file
S. Eleonore KöhlerS. Eleonore Köhler
S. Eleonore Köhler
SSSelvakumari Sankaranarayanan
Selvakumari Sankaranarayanan
CGChris Van Ginneken
Chris Van Ginneken
PDPaul van Dijk
Paul van Dijk
JVJacqueline Lm Vermeulen
Jacqueline Lm Vermeulen
EBElisabeth Bruder
Elisabeth Bruder
Background: Milk contains too little arginine for normal growth, but its precursors proline and glutamine are abundant; the small intestine of rodents and piglets produces arginine from proline during the suckling period; and parenterally fed premature human neonates frequently suffer from hypoargininemia. These findings raise the question whether the neonatal human small intestine also expresses the enzymes that enable the synthesis of arginine from proline and/or glutamine.Carbamoylphosphate synthetase (CPS), ornithine aminotransferase (OAT), argininosuccinate synthetase (ASS), arginase-1 (ARG1), arginase-2 (ARG2), and nitric-oxide synthase (NOS) were visualized by semiquantitative immunohistochemistry in 89 small-intestinal specimens.Results: Between 23 weeks of gestation and 3 years after birth, CPS- and ASS-protein content in enterocytes was high and then declined to reach adult levels at 5 years. OAT levels declined more gradually, whereas ARG-1 was not expressed. ARG-2 expression increased neonatally to adult levels. Neurons in the enteric plexus strongly expressed ASS, OAT, NOS1 and ARG2, while varicose nerve fibers in the circular layer of the muscularis propria stained for ASS and NOS1 only. The endothelium of small arterioles expressed ASS and NOS3, while their smooth-muscle layer expressed OAT and ARG2.Conclusion: The human small intestine acquires the potential to produce arginine well before fetuses become viable outside the uterus. The perinatal human intestine therefore resembles that of rodents and pigs. Enteral ASS behaves as a typical suckling enzyme because its expression all but disappears in the putative weaning period of human infants.

1 October 2007 in Laboratory Investigation
Verified
Journal Article
Closed access
PDF file
EBElisabeth Bruder
Elisabeth Bruder
JHJörg Hofmeister
Jörg Hofmeister
CACharalampos Aslanidis
Charalampos Aslanidis
JHJürg Hammer
Jürg Hammer
LBLukas Bubendorf
Lukas Bubendorf
CBChristoph Bührer
Christoph Bührer

1 June 2008 in Pathobiology
Verified
Journal Article
Closed access
PDF file
WMWilliam A. Meier-Ruge
William A. Meier-Ruge
EBElisabeth Bruder
Elisabeth Bruder
Enzyme histochemistry serves as a link between biochemistry and morphology. It is based on metabolization of a substrate provided to a tissue enzyme in its orthotopic localization. Visualization is accomplished with an insoluble dye product. It is a sensitive dynamic technique that mirrors even early metabolic imbalance of a pathological tissue lesion, combined with the advantage of histotopographic enzyme localization. With the advent of immunohistochemistry and DNA-oriented molecular pathology techniques, the potential of enzyme histochemistry currently tends to be underrecognized. This review aims to draw attention to the broad range of applications of this simple, rapid and inexpensive method. Alkaline phosphatase represents tissue barrier functions in brain capillaries, duodenal enterocyte and proximal kidney tubule brush borders. Decrease in enzyme histochemical alkaline phosphatase activity indicates serious functional impairment. Enzyme histochemical increase in lysosomal acid phosphatase activity is an early marker of ischemic tissue lesions. Over the last four decades, acetylcholinesterase enzyme histochemistry has proven to be the gold standard for the diagnosis of Hirschsprung disease and is one of the most commonly applied enzyme histochemical methods today. Chloroacetate esterase and tartrate-resistant phosphatase are both resistant to formalin fixation, EDTA decalcification and paraffin embedding. Early enzyme histochemical insight into development of a pathologic tissue lesion and evaluation of function and vitality of tissue enhance our understanding of the pathophysiology of diseases. In this process, enzyme histochemistry constitutes a valuable complement to conventional histology, immunohistochemistry and molecular pathology for both diagnostic and experimental pathology.

26 February 2013 in European Journal of Pediatric Surgery
Verified
Journal Article
Closed access
PDF file
Johannes MayrJohannes Mayr
Johannes Mayr
EBElisabeth Bruder
Elisabeth Bruder
FHFrank-Martin Haecker
Frank-Martin Haecker
SSSergio B. Sesia
Sergio B. Sesia
Background The proliferation of nerve fibers in the appendix, in association with an increase of the neuropeptides such as vasoactive intestinal peptide and substance P characterizes neurogenic appendicopathy (NA), which may mimic the symptoms of acute appendicitis (AA). It may be difficult to differentiate this little known distinct pathological entity clinically from AA. The aim of this study is to describe the epidemiology, clinical signs, and histological description of NA in pediatric patients. Patients and Methods After institutional review board approval, all appendiceal specimens from children who underwent appendectomy between February 2006 and December 2008 were analyzed. Analysis included age, gender, clinical symptoms, blood tests, intraoperative macroscopic assessment of the appendix, and the histopathological type of NA. NA was diagnosed by hematoxylin–eosin staining and /or S-100 immunochemistry and then classified into different histopathological groups. Results Of the 385 appendix specimens examined, 29 (7.5%) met the histopathological criteria of NA. The median duration of abdominal pain was 2 days (range, 1 to 7). The surgeon characterized the appendix as follows: not inflamed in 5 (17.2%), acute in 17 (58.6%), phlegmonous in 4 (13.8%), and perforated in 3 patients (10.4%). Histopathological diagnosis of NA classified the specimen as axial neuroma in 2 (7%), mucosal in 12 (41%), and submucosal in 15 cases (52%). Conclusion NA is a relatively common diagnosis in children. NA must be considered in patients with recurrent right lower quadrant pain or signs of AA, even if intraoperative findings are normal. For these patients, we recommend appendectomy and consideration of a subsequent histopathological workup.